|
⚲
|
| Keyboard |
| Daniel Tasse | |
|---|---|
| Firm | |
| Address | c/o Dbv Technologies Sa 107 Avenue de La Republique Chatillon, I0 92320 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| DBV Technologies Sa | 021-543990 | Executive Officer | 306.9 M of 306.9 M |
||
| BIOQ Pharma Inc | 021-357701 | Director | 4.6 M of 18.8 M |
||
| Bellerophon Therapeutics Inc | 021-296368 | Director | 23.4 M of 23.4 M |
||
| Alcresta Therapeutics Inc | 021-295327 | Executive Officer | 10.0 M of 35.0 M |
||
| BIOQ Pharma Inc | 021-292569 | Director | 6.2 M of 6.2 M |
||
| Bellerophon Therapeutics Inc | 021-287121 | Director | 1.6 M of 1.6 M |
||
| BIOQ Pharma Inc | 021-272968 | Director | 15.0 M of 15.0 M |
||
| Alcresta Therapeutics Inc | 021-264996 | Executive Officer | 50.9 M of 50.9 M |
||
| BIOQ Pharma Inc | 021-253093 | Director | 36.4 M of 45.0 M |
||
| Bellerophon Therapeutics LLC | 021-220220 | Director | 0.0 M of 0.0 M |
||
| Compound Holdings I LLC | 021-212385 | Executive Officer | 412.0 M of 412.0 M |
||
| Bellerophon Therapeutics LLC | 021-212315 | Executive Officer | 0.0 M of 0.0 M |
||
| Ikaria Holdings Inc | 021-102325 | Executive Officer | 54.9 M | ||